| Symbol | PRPO |
|---|---|
| Name | PRECIPIO, INC. |
| Sector | INDUSTRIALS |
| Region | North America |
| Industry | Biotechnology: Laboratory Analytical Instruments |
| Address | 4 SCIENCE PARK, NEW HAVEN, Connecticut, 06511, United States |
| Telephone | +1 203 787-7888 |
| Fax | — |
| — | |
| Website | https://www.precipiodx.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001043961 |
| Description | Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provide new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. Additional info from NASDAQ: |
Precipio is requesting Shareholders/Brokers vote today to avoid costly adjournment and rescheduling of Annual Shareholders Meeting
Read morePrecipio is requesting Shareholders/Brokers vote today to avoid costly adjournment and rescheduling of Annual Shareholders Meeting
Read moreDirector SANDBERG RICHARD A 🔴 sold 900 shares of Precipio, Inc. (PRPO) at $25.02 Transaction Date: May 21, 2026 | Filing ID: 066246
Read more📋 SANDBERG RICHARD A (Director) plans to sell 4K shares of Precipio, Inc. (at $24.85 each, total $100K) Filed: May 19, 2026 | ID: 000298
Read more